Pesquisa | Biblioteca Virtual em Saúde

1.

Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.

Byrd, John C; Ruppert, Amy S; Mrózek, Krzysztof; Carroll, Andrew J; Edwards, Colin G; Arthur, Diane C; Pettenati, Mark J; Stamberg, Judith; Koduru, Prasad R K; Moore, Joseph O; Mayer, Robert J; Davey, Frederick R; Larson, Richard A; Bloomfield, Clara D.

J Clin Oncol ; 22(6): 1087-94, 2004 Mar 15.

Artigo em Inglês | MEDLINE | ID: mdl-15020610

2.

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

Moore, Joseph O; George, Stephen L; Dodge, Richard K; Amrein, Philip C; Powell, Bayard L; Kolitz, Jonathan E; Baer, Maria R; Davey, Frederick R; Bloomfield, Clara D; Larson, Richard A; Schiffer, Charles A.

Blood ; 105(9): 3420-7, 2005 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-15572587

3.

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.

Sekeres, Mikkael A; Peterson, Bercedis; Dodge, Richard K; Mayer, Robert J; Moore, Joseph O; Lee, Edward J; Kolitz, Jonathan; Baer, Maria R; Schiffer, Charles A; Carroll, Andrew J; Vardiman, James W; Davey, Frederick R; Bloomfield, Clara D; Larson, Richard A; Stone, Richard M.

Blood ; 103(11): 4036-42, 2004 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-14976037

4.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

Byrd, John C; Mrózek, Krzysztof; Dodge, Richard K; Carroll, Andrew J; Edwards, Colin G; Arthur, Diane C; Pettenati, Mark J; Patil, Shivanand R; Rao, Kathleen W; Watson, Michael S; Koduru, Prasad R K; Moore, Joseph O; Stone, Richard M; Mayer, Robert J; Feldman, Eric J; Davey, Frederick R; Schiffer, Charles A; Larson, Richard A; Bloomfield, Clara D.

Blood ; 100(13): 4325-36, 2002 Dec 15.

Artigo em Inglês | MEDLINE | ID: mdl-12393746

5.

Biology and epidemiology of human t-cell leukemia/lymphoma virus

Poiesz, Bernard J; Moore, Janet L; Merl, Stuart A; Tomar, Russell H; Zamkoff, Kenneth W; Davey, Frederick R; Planas, Antonio T; Gottlieb, Arlan J; Runge, Lorne A; Cowan, Bennet Y; Reeves, William G; Enhrlich, Garth; Ruscetti, Francis W; Han, Tin; Cabradilla, Cy D; Comis, Robert L.

In. Gallo, Robert C; Essex, Myron E; Groos, Ludwik. Human T-cell leukemia/lymphoma virus - the family of human T-lymphotropic retroviruses: their role in malignancies and association with aids. New York, Cold Spring Harbor Laboratory, 1984. p.237-245, tab, graf.

Monografia em Inglês | SES-SP, SESSP-IALACERVO | ID: biblio-1070092

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

Biology and epidemiology of human t-cell leukemia/lymphoma virus